MMD CONSULTING

Vision Execution: providing thoughtful solutions to complex puzzles

vision executor | Project and Portfolio Management | Business Operations | community Coach |

What is a Vision Executor?

A Vision Executor is a trusted team member who implements near-term strategy for long-term successs. As Vision Executor, I partner with you to define, plan and execute a transformational journey to move from present state to future state. We develop a comprehensive and step by step vision and execute together in a timebound manner.

Empowering Your Vision with Strategic Excellence

 

 

Let's partner to navigate the complex journey from discovery to clinic with greater confidence and efficiency. Combining deep scientific knowledge with business acumen, we can accelerate the path to patient accesibilty and profitability

 

Looking to come alongside founders and executive leaders to develop straetgic roadmaps that transform academic discoveries into clinically tested therapeutics, optimizing early fundraising activites and defining clear milestones that attract new investors.

 

Comprehensive services designed to unlock your organization's full potential through strategic planning, operational excellence, and visionary leadership.

 

 

Transform Scientific Breakthroughs into Clinical Realities

Meet the Founder

BS in Chemsitry, University of the Ozarks

PhD in Biochemistry, University of Delaware

Postdoctoral Training, Drexel University

 

Sr Project Manager, Gene Therapy Program, Penn

Director of Operations, Cabaletta Bio

Sr Clinical Analyst, Foresite Capital Mgmt

 

Just call me your right hand gal! I am a biochemist by training, a highly collaborative person with a mind for project management, and a vision caster who loves to turn an idea into an actionable plan. My passion and experience is in driving collaboration between academia and industry to accelerate the path from scientific breakthrough to clinic. This unique combination of scientific knowledge and business experience allows me to understand both the technical challenges of therapeutic development and the strategic requirements for business success in the biotech ecosystem. 

  • While at University of Pennsylvania's Gene Therapy Program, I successfully managed a $50M gene therapy research portfolio that formed the basis for several spin out companies including RegenxBio, Passage Bio, and ScoutBio.

  • As Director of Operations at Cabaletta Bio, I oversaw product development planning for multiple cell therapies for autoimmune conditions, managing tech transfer, IND-enabling studies, manufacturing POC, and regulatory approval into Phase I clinical trials. 

  • At Foresite Capital Management, I supported clinical landscape analysis, portfolio management and capital planning for a subset of the $4b healthcare portfolio.